tiprankstipranks
Cullinan Management (CGEM)
NASDAQ:CGEM

Cullinan Management Stock Analysis & Ratings

CGEM Stock Chart & Stats

Day’s Range$11.03 - $12.39
52-Week Range$7.30 - $37.66
Previous Close$10.88
Volume1.96M
Average Volume (3M)389.95K
Market Cap$539.63M
P/E Ratio-8.1
Beta0.21
Next EarningsN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score2
EPS (TTM)-1.49


Financials

Currently, no data available
Please return soon. This page is being updated.

P/E Ratio Range

Currently, no data available
Please return soon. This page is being updated.
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

CGEM FAQ

What was Cullinan Management’s price range in the past 12 months?
Cullinan Management lowest stock price was $7.30 and its highest was $37.66 in the past 12 months.
    What is Cullinan Management’s market cap?
    Cullinan Management’s market cap is $539.63M.
      What is Cullinan Management’s price target?
      The average price target for Cullinan Management is $37.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $50.00 ,the lowest forecast is $25.00. The average price target represents 211.20% Increase from the current price of $12.05.
        What do analysts say about Cullinan Management?
        Cullinan Management’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
          When is Cullinan Management’s upcoming earnings report date?
          The company’s upcoming earnings report date is not yet available.
          How were Cullinan Management’s earnings last quarter?
          Currently, no data Available
          Is Cullinan Management overvalued?
          According to Wall Street analysts Cullinan Management’s price is currently Undervalued.
            Does Cullinan Management pay dividends?
            Cullinan Management does not currently pay dividends.
            What is Cullinan Management’s EPS estimate?
            Cullinan Management’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Cullinan Management have?
            Cullinan Management has 44,780,000 shares outstanding.
              What happened to Cullinan Management’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Cullinan Management?
              Among the largest hedge funds holding Cullinan Management’s share is Baupost Group LLC. It holds Cullinan Management’s shares valued at 16M.

                ---

                Cullinan Management Stock Analysis

                Smart Score
                2
                Underperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                Price Target
                $37.50
                ▲(211.20% Upside)
                Moderate Buy
                The Cullinan Management stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Cullinan Management

                Cullinan Management Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

                ---
                Similar Stocks
                No data currently available

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis